SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending after delivering a massive earnings beat and issuing exceptionally strong guidance, driven by robust AI memory demand. The community is actively discussing numerous analyst upgrades and views this as strong confirmation that the AI trade is accelerating, despite recent market volatility in the sector.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending following renewed discussions about marijuana reclassification, fueling a retail frenzy within the crypto community. While many enthusiasts are rallying around the token, comparing it to Bitcoin and emphasizing its role in cannabis culture, others express skepticism, questioning its legitimacy and labeling it a potential 'scam coin'.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is actively trending after applying to establish PayPal Bank, aiming to expand small business lending and offer savings accounts, alongside its PYUSD stablecoin developments and recent tech partnerships. This strategic move has sharply divided the community, with many viewing it as a significant catalyst for new revenue streams and a sign of deep undervaluation, while others express frustration, labeling it a 'boring bank' that warrants a lower valuation and continued price pressure. The ongoing debate reflects broader uncertainty about the company's trajectory and management's ability to drive stock performance despite strong fundamentals and consistent share buybacks.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Galectin Therapeutics ($GALT) is trending as the community eagerly awaits FDA guidance by year-end on its lead drug candidate, belapectin, for MASH cirrhosis, an area with no approved treatments. Optimism is high following positive NAVIGATE trial data, with discussions centering on the drug's 

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid widespread anticipation of a potential executive order expected to reclassify marijuana to Schedule III, a move viewed as a significant catalyst for the cannabis sector. The community is actively debating the profound financial implications, particularly around tax relief and increased institutional investment, leading to strong bullish sentiment. However, a parallel conversation explores whether this anticipated news is already priced into current valuations, or if a 'sell the news' reaction could unfold.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. is trending following news that its Santa Ynez pipeline has been confirmed as an interstate and active facility under federal rules, potentially shifting regulatory oversight. This development is fueling significant community discussion around a potential short squeeze and accelerated oil production, contrasting with lingering skepticism about local regulatory hurdles and the company's financial outlook.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending due to significant advancements in its AI ecosystem, including reports of Meta Platforms utilizing its Qwen model for AI training and the launch of new AI-powered Quark smart glasses. The community is actively discussing the global expansion and AI-driven innovation of Ant International's payment and digitization services. Many investors view the stock as an undervalued AI play, anticipating continued growth from China's focus on advanced technology and potential economic stimulus.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PMV CRYPTO is trending with its highly engaged "infected squad" community vigorously spreading its "PumpMindVirus" meme culture across the Solana ecosystem. The community is generating significant buzz through consistent daily activity, emphasizing organic growth, and an ambitious "Viral Agenda" extending into 2026 and 2027, driving lively conversations about its long-term potential and unique community spirit.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as its dedicated community rallies around a return to "OG Memes" and "2021 vibes," fueled by a strong belief in the project's foundational lore and consistent building efforts. Discussions highlight significant community growth, the ongoing RageGames tournaments, and anticipation for major exchange listings like Coinbase and Kraken, embodying a bullish conviction for future expansion.

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Vero Beach, FL.

Processa Pharmaceuticals Inc

Processa Pharmaceuticals (PCSA) is trending due to positive Phase 2 clinical trial data for its cancer treatment, which demonstrated improved efficacy with reduced toxicity. This news has ignited fervent community discussion, with bulls anticipating further gains and a potential short squeeze, while others express skepticism, citing the stock's history of volatility, recent reverse split, and concerns over potential dilution or a pump and dump.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CNA beats earnings expectations with core earnings per share exceeding estimates by 20%!

Core earnings hit $1.50 per share, up 39% year over year, driven by higher income from fixed income securities and improved underwriting results due to lower catastrophe losses. However, total operating revenues of $3.4 billion narrowly missed estimates.

Discover more on CNA&#39;s performance and outlook 👉 https://www.zacks.com/stock/news/2784499/cna-financial-q3-earnings-beat-estimates-on-solid-underwriting?cid=sm-stocktwits-2-2784499-body-19287&amp;ADID=SYND_STOCKTWITS_TWEET_2_2784499_BODY_19287

Zacks

Pardon Our Interruption

Zacks Research

CNA Financial Corp.

 beats earnings expectations with core earnings per share exceeding estimates by 20%!

Core earnings hit $1.50 per share, up 39% year over year, driven by higher income from fixed income securities and improved underwriting results due to lower catastrophe losses. However, total operating revenues of $3.4 billion narrowly missed estimates.

Discover more on CNA's performance and outlook 👉 

This account is recognized as an Official Stocktwits Research Partner — working in close collaboration with Stocktwits to deliver in-depth research and market analysis.